From 6–9 May 2025, the Netherlands Embassy in Seoul, in collaboration with the Netherlands Enterprise Agency (RVO), is organising a trade mission to South Korea focused on the biotech sector. This is a unique opportunity for Dutch biotech companies to explore the South Korean market, attend the international BIO KOREA exhibition, and connect with Korean companies and stakeholders.
Companies can join a curated programme including access to the BIO KOREA trade fair, matchmaking sessions, company visits, and networking events. Eugene Kim, from the Netherlands Embassy in Seoul, is currently working on a strong programme tailored to Dutch biotech interests.
South Korea offers exciting opportunities for companies involved in innovation, drug development, and medical technologies. With growing demand and a well-established biotech infrastructure, it’s a market worth exploring.
There’s already strong interest from the Dutch business community, but a few spots are still available. Want to join and tap into South Korea’s biotech potential?
Check the full programme and register via the RVO website.
The Court of Audit visited LBSP to explore how science and entrepreneurship create public value, with stops at TNO, Peregrion, NTrans, and VarmX sparking discussion on biotech innovation.
Leiden University is studying emotions at Lowlands Festival through two projects: a haunted house that measures how people cope with fear, and a silent performance exploring nonverbal communication.
LUMC and Stichting DON have launched Cure One, a new research center focused on accelerating curative therapies for type 1 diabetes through stem cell technology and immune-based treatments.